Synthesis of novel metabolically stable analogues of D-myo-inositol 1,4,5-trisphosphate

Tetrahedron Letters

Volumn 37, Issue 12, 1996, Pages 1917-1920

  Fauq, Abdul H ^a   Zaidi, Javid H ^a   Wilcox, Robert A ^b   Varvel, Girlie ^a   Nahorski, Stefan R ^b   Kozikowski, Alan P ^c   Erneux, Christophé ^d  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c GEORGETOWN UNIVERSITY   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE DERIVATIVE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; INOSITOL DERIVATIVE;

ANIMAL TISSUE; ARTICLE; BRAIN; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CONTROLLED STUDY; DRUG RECEPTOR BINDING; DRUG STABILITY; DRUG SYNTHESIS; NEUROBLASTOMA CELL; NONHUMAN; REACTION ANALYSIS; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; SWINE;

EID: 0029933523     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4039(96)00169-4     Document Type: Article

References (18)

1. (a) Berridge, M. J. Annu. Rev. Biochem. 1987, 56, 159-193.
2. (b) Berridge, M. J. Nature 1993, 315-325.
3. (c) Shears, S. B. In Advances in Second Messenger and Phosphoprotein Research, Putney, J. W., Jr., Ed.; Raven Press Ltd., New York, 1992; Vol. 26; pp 63-92.
4. Billington, D. C.; The Inositol Phosphates: Chemical Synthesis and Biological Significance; VCH Verlagsgesellschaft, Weinheim, FRG, 1993.
5. (a) Potter, B. V. L. In Trends in Receptor Research; Classen, V., Ed.; Elsevier Science Publishers B. V. London, 1993; pp 185-214.
6. (b) Nahorski, S. R.; Potter, B. V. L. Trends Pharmacol. Sci. 1989, 10, 139-143.
7. (a) C-F bond: Welch, C. T. Selective Fluorination in Organic and Bioorganic Chemistry; American Chemical Society: Washington, D.C., 1991.
8. (b) Filler, R.; Kobayashi, Y. Biochemical Aspects of Fluorine Chemistry; Elsevier Biomedical Press and Kodansha Ltd., New York, 1982.
9. (a) Taylor, C. W.; Berridge, M. J.; Brown, K. D.; Cooke, A. M.; Potter, B. V. L. Biochem. Biophys. Res. Commun. 1988, 150, 626-632.
10. (b) Willems, H. A. M.; Veeneman, G. H.; Westerduin, P. Tetrahedron Lett. 1992, 33, 2075-2078.
11. (c) Dreef, C. E.; Mayr, G. W.; Jansze, J.-P.; Roelen, H. C. P. F.; van der Marel, G. A.; van Boom, J. H. BioMed. Chem. Lett. 1991, 1, 239-242.
12. (d) Wilcox, R. A.; Challiss, R. A. J.; Traynor, J. R.; Fauq, A. H.; Ognyanov, V. I.; Kozikowski, A. P.; Nahorski, S. R. J. Biol. Chem. 1994, 269, 26815-26821.
13. 3 analogues showed any signs of decomposition over a period of several weeks at 25 °C.
14. Kozikowski, A. P.; Fauq, A. P.; Rusnak, J. M. Tetrahedron Lett. 1989, 30, 3365-3368.
15. 1H NMR double resonance experiments.
16. Khorana, H. G.; Todd, H. J. Chem. Soc. 1953, 2257.
17. Kamer, P. C. J.; Roelen, H. C. P. F.; van der Elst, H.; van der Marel, G. A.; van Boom, J. H. Tetrahedron Lett. 1989, 30, 6757-6760.
18. +-1).